6.99
price up icon9.73%   0.62
after-market Handel nachbörslich: 7.00 0.010 +0.14%
loading
Schlusskurs vom Vortag:
$6.37
Offen:
$6.27
24-Stunden-Volumen:
103.41K
Relative Volume:
1.57
Marktkapitalisierung:
$204.09M
Einnahmen:
$65.42M
Nettoeinkommen (Verlust:
$-32.96M
KGV:
-4.1118
EPS:
-1.7
Netto-Cashflow:
$-19.87M
1W Leistung:
+7.70%
1M Leistung:
+2.34%
6M Leistung:
-48.75%
1J Leistung:
-2.51%
1-Tages-Spanne:
Value
$6.27
$7.15
1-Wochen-Bereich:
Value
$6.03
$7.15
52-Wochen-Spanne:
Value
$5.45
$18.15

Neuropace Inc Stock (NPCE) Company Profile

Name
Firmenname
Neuropace Inc
Name
Telefon
(650) 237-2700
Name
Adresse
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Name
Mitarbeiter
179
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
NPCE's Discussions on Twitter

Neuropace Inc Stock (NPCE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-08-24 Hochstufung Morgan Stanley Underweight → Equal-Weight
2023-02-22 Eingeleitet Lake Street Buy
2022-04-06 Eingeleitet Wolfe Research Outperform
2022-01-19 Herabstufung Wells Fargo Overweight → Equal Weight
2022-01-07 Herabstufung Morgan Stanley Equal-Weight → Underweight
2021-11-11 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-08-18 Eingeleitet Robert W. Baird Outperform
2021-05-17 Eingeleitet JP Morgan Overweight
2021-05-17 Eingeleitet Morgan Stanley Overweight
2021-05-17 Eingeleitet SVB Leerink Outperform
2021-05-17 Eingeleitet Wells Fargo Overweight
Alle ansehen

Neuropace Inc Aktie (NPCE) Neueste Nachrichten

pulisher
08:17 AM

NeuroPace (NPCE) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat

08:17 AM
pulisher
Nov 04, 2024

NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy - ForexTV.com

Nov 04, 2024
pulisher
Nov 04, 2024

NeuroPace submits RNS System study data to FDA - Investing.com

Nov 04, 2024
pulisher
Nov 03, 2024

How to Take Advantage of moves in (NPCE) - Stock Traders Daily

Nov 03, 2024
pulisher
Nov 03, 2024

Analysts Set NeuroPace, Inc. (NASDAQ:NPCE) Target Price at $14.00 - Defense World

Nov 03, 2024
pulisher
Oct 31, 2024

NeuroPace, Inc. (NASDAQ:NPCE) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Oct 31, 2024
pulisher
Oct 29, 2024

Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength? - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Deep Brain Stimulation Devices Market Growing Popularity & Emerging Trends | Medtronic, NeuroPace, LivaNova - openPR

Oct 29, 2024
pulisher
Oct 28, 2024

KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares - Yahoo Finance

Oct 28, 2024
pulisher
Oct 28, 2024

Neuropace shareholder KCK Ltd. sells $1.22 million in stock By Investing.com - Investing.com South Africa

Oct 28, 2024
pulisher
Oct 28, 2024

Neuropace shareholder KCK Ltd. sells $1.22 million in stock - Investing.com

Oct 28, 2024
pulisher
Oct 28, 2024

Ltd. Kck Sells 223,991 Shares of NeuroPace, Inc. (NASDAQ:NPCE) Stock - MarketBeat

Oct 28, 2024
pulisher
Oct 24, 2024

KCK LTD. Adjusts Stake in NeuroPace Inc - GuruFocus.com

Oct 24, 2024
pulisher
Oct 24, 2024

Neuropace Inc sees $24,853 stock sale by major shareholder - Investing.com

Oct 24, 2024
pulisher
Oct 24, 2024

Page 85 – Impact Investing - Equities News

Oct 24, 2024
pulisher
Oct 23, 2024

Neuropace stock hits 52-week low at $5.66 amid market challenges - Investing.com Australia

Oct 23, 2024
pulisher
Oct 23, 2024

NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024 - The Manila Times

Oct 23, 2024
pulisher
Oct 22, 2024

Neuropace sees $53,370 in stock sales by major shareholder - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

NeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Ltd. Kck Sells 3,720 Shares - MarketBeat

Oct 22, 2024
pulisher
Oct 19, 2024

Neuropace Inc: KCK Ltd. sells $303,366 in shares By Investing.com - Investing.com South Africa

Oct 19, 2024
pulisher
Oct 19, 2024

Neuropace Inc: KCK Ltd. sells $303,366 in shares - Investing.com India

Oct 19, 2024
pulisher
Oct 18, 2024

KCK LTD. Reduces Stake in NeuroPace Inc - GuruFocus.com

Oct 18, 2024
pulisher
Oct 18, 2024

Insider Selling: NeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Sells 2,572 Shares of Stock - MarketBeat

Oct 18, 2024
pulisher
Oct 17, 2024

NeuroPace Continues to Strengthen Management Team - The Manila Times

Oct 17, 2024
pulisher
Oct 16, 2024

NeuroPace appoints new VP of Human Resources - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

NeuroPace appoints new VP of Human Resources By Investing.com - Investing.com UK

Oct 16, 2024
pulisher
Oct 13, 2024

Marshall Wace LLP Sells 26,313 Shares of NeuroPace, Inc. (NASDAQ:NPCE) - Defense World

Oct 13, 2024
pulisher
Oct 12, 2024

Millennium Management LLC Acquires 80,324 Shares of NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat

Oct 12, 2024
pulisher
Oct 11, 2024

Augmented Humanity Technologies Industry to Witness Growth Acceleration by (2024-2034) - IndiaPolitics.com

Oct 11, 2024
pulisher
Oct 11, 2024

Brain Computer Interface (BCI) Industry – Key Innovations and Future Market Scope - TIMC

Oct 11, 2024
pulisher
Oct 11, 2024

Neurostimulation Devices Market is Estimated to Reach $11.26 Billion By 2032 - 대구포스트

Oct 11, 2024
pulisher
Oct 10, 2024

Implantable Pulse Generator Market Report 2024: Size, Share, Growth, Forecast to 2033 - WhaTech

Oct 10, 2024
pulisher
Oct 09, 2024

Neuroscience Industry Report By Type, Application and Geography - Elektrotransports.lv

Oct 09, 2024
pulisher
Oct 09, 2024

Digital Health Monitoring Devices Industry Business Development, Trends - Elektrotransports.lv

Oct 09, 2024
pulisher
Oct 08, 2024

Cubist Systematic Strategies LLC Decreases Stock Holdings in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World

Oct 08, 2024
pulisher
Oct 07, 2024

Matthias Stangl Receives R00 Grant from NIH - Boston University

Oct 07, 2024
pulisher
Oct 06, 2024

Brokerages Set NeuroPace, Inc. (NASDAQ:NPCE) Target Price at $14.00 - MarketBeat

Oct 06, 2024
pulisher
Oct 04, 2024

Down Over 60% In 3 Months, Will NeuroPace Stock Regain Its Pace? - RTTNews

Oct 04, 2024
pulisher
Oct 01, 2024

Trading (NPCE) With Integrated Risk Controls - Stock Traders Daily

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Reduces Holdings in NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

XTX Topco Ltd Increases Stock Position in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Rhumbline Advisers Takes $111,000 Position in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World

Oct 01, 2024
pulisher
Sep 30, 2024

NeuroPace's SWOT analysis: epilepsy device maker's stock poised for growth By Investing.com - Investing.com Australia

Sep 30, 2024
pulisher
Sep 29, 2024

NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up - MSN

Sep 29, 2024
pulisher
Sep 27, 2024

34,059 Shares in NeuroPace, Inc. (NASDAQ:NPCE) Acquired by Bank of New York Mellon Corp - Defense World

Sep 27, 2024
pulisher
Sep 26, 2024

BCI and EEG Market Future Developments, Upcoming Trends, and Top-Vendor Landscape 2020 to 2032 Medtronic, Natus Medical, Nihon Kohden, NeuroPace Inc – Cauverynews - Cauverynews

Sep 26, 2024
pulisher
Sep 23, 2024

National Bank of Canada (OTCMKTS:NTIOF) Hits New 1-Year High at $94.20 - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Understanding the Risks of Investing in Noble Corp Plc (NE) - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Nothing is Better Than New Found Gold Corp (NFGC) stock at the moment - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Internal Neuromodulation Devices Market Size, Trends And Forecast 2024-2033 - WhaTech

Sep 23, 2024

Finanzdaten der Neuropace Inc-Aktie (NPCE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices ZBH
$108.92
price up icon 0.47%
medical_devices STE
$227.44
price up icon 0.72%
medical_devices PHG
$27.08
price up icon 0.00%
$69.00
price down icon 1.00%
$88.17
price up icon 1.36%
medical_devices EW
$66.69
price up icon 0.33%
Kapitalisierung:     |  Volumen (24h):